Rapport Therapeutics, Inc. financial data

Symbol
RAPP on Nasdaq
Location
1325 Boylston Street, Suite 401, Boston, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 36.6M shares
Common Stock, Shares, Outstanding 36.6M shares
Common Stock, Value, Issued 36K USD
Weighted Average Number of Shares Outstanding, Basic 10.7M shares +641%
Weighted Average Number of Shares Outstanding, Diluted 10.7M shares +641%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 15.7M USD +232%
General and Administrative Expense 5.11M USD +168%
Operating Income (Loss) -20.8M USD -214%
Nonoperating Income (Expense) 2.68M USD +1112%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -18.1M USD -183%
Net Income (Loss) Attributable to Parent -18.1M USD -183%
Earnings Per Share, Basic -1.7 USD/shares +61.8%
Earnings Per Share, Diluted -1.7 USD/shares +61.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 110M USD +38.5%
Cash, Cash Equivalents, and Short-term Investments 336M USD
Assets, Current 341M USD
Property, Plant and Equipment, Net 3.47M USD
Operating Lease, Right-of-Use Asset 1.77M USD
Other Assets, Noncurrent 189K USD
Assets 346M USD
Accounts Payable, Current 1.88M USD
Employee-related Liabilities, Current 1.71M USD
Accrued Liabilities, Current 5.52M USD
Liabilities, Current 8.1M USD
Operating Lease, Liability, Noncurrent 1.12M USD
Liabilities 9.21M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -183K USD
Retained Earnings (Accumulated Deficit) -86.2M USD
Stockholders' Equity Attributable to Parent 337M USD
Liabilities and Equity 346M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 500M shares
Common Stock, Shares, Issued 36.6M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Depreciation 200K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -18.1M USD -183%
Property, Plant and Equipment, Gross 3.96M USD
Operating Lease, Liability, Current 703K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 2.35M USD +149%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares